First antiviral drug approved to fight coronavirus
This Photo is owned by INQUIRER.NET
Favilavir, formerly known as Fapilavir, an antiviral that has shown efficacy in treating the novel coronavirus, was approved for marketing, the Taizhou government in Zhejiang province announced Sunday.
It is the first anti-novel coronavirus drug that has been approved for marketing by the National Medical Products Administration since the outbreak. Developed by Zhejiang Hisun Pharmaceutical Company, the drug is expected to play an important role in preventing and treating the epidemic, the government said on its official WeChat account.
Favilavir is one of three drugs that have shown significant efficacy in treating the novel coronavirus in clinical trials, the Ministry of Science and Technology said on Saturday.
The antiviral was put into production on Sunday.
Zhejiang province has reported 1,167 cases so far.
This article is taken from China Daily By Zhang Yangfei | chinadaily.com.cn | Updated: 2020-02-17 09:43
Back in December last year, he was arrested for being a whistleblower ‘spreading rumors’ about the mysterious pneumonia-like virus. This morning we found out he was, in fact, a fellow brother in Christ. Our hearts are deeply moved by his sacrificial choice to spread awareness about the virus despite the risks he faced, especially to his reputation and to his own health.